BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26641707)

  • 1. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
    Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
    J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
    Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
    Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
    Nielsen LM; Holm NB; Olsen L; Linnet K
    Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
    Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
    Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
    Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
    Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and pharmacokinetics of allitinib in cancer patients: the roles of cytochrome P450s and epoxide hydrolase in its biotransformation.
    Lin L; Xie C; Gao Z; Chen X; Zhong D
    Drug Metab Dispos; 2014 May; 42(5):872-84. PubMed ID: 24598282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved.
    Erratico CA; Szeitz A; Bandiera SM
    Chem Res Toxicol; 2013 May; 26(5):721-31. PubMed ID: 23537005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS.
    Kim U; Jin MJ; Lee J; Han SB; In MK; Yoo HH
    J Pharm Biomed Anal; 2012 May; 64-65():26-34. PubMed ID: 22405558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism of tussilagone in rat and human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.
    Zhang XS; Ren W; Bian BL; Zhao HY; Wang S
    Rapid Commun Mass Spectrom; 2015 Sep; 29(18):1641-50. PubMed ID: 26467116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro drug metabolism of green tea catechins in human, monkey, dog, rat and mouse hepatocytes.
    Chen WW; Qin GY; Zhang T; Feng WY
    Drug Metab Lett; 2012 Jun; 6(2):73-93. PubMed ID: 22594564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.
    Holm NB; Nielsen LM; Linnet K
    AAPS J; 2015 Sep; 17(5):1237-45. PubMed ID: 26002511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
    Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
    Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s.
    Breinholt VM; Rasmussen SE; Brøsen K; Friedberg TH
    Pharmacol Toxicol; 2003 Jul; 93(1):14-22. PubMed ID: 12828569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of novel anti-HIV agent 3-cyanomethyl-4-methyl-DCK by human liver microsomes and recombinant CYP enzymes.
    Zhuang XM; Deng JT; Li H; Kong WL; Ruan JX; Xie L
    Acta Pharmacol Sin; 2011 Oct; 32(10):1276-84. PubMed ID: 21970838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.